Search Results

11 - 20 of 66 items :

  • Quality of life x
  • Endocrinology, Diabetology x
Clear All
Prevalence of Hypoglycemia, Treatment Satisfaction, Adherence and Their Associations with Glycemic Goals in Patients with Type 2 Diabetes Mellitus Treated with Sulfonylureas: Findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) in Romania

diabetes control and complications trial. Diabetes Care . Nov 1995;18(11):1415-1427. 10. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ . Aug 12 2000;321(7258): 405-412. 11. Lundkvist J, Berne C, Bolinder B, Jonsson L. The economic and quality of life impact of hypoglycemia. Eur J Health Econ . Sep 2005;6(3):197-202. 12. Vexiau P, Mavros P, Krishnarajah G, Lyu R, Yin D. Hypoglycaemia in patients with type 2

Open access
PreSSUB II: The prehospital stroke study at the Universitair Ziekenhuis Brussel II

of handicap in stroke patients. Stroke 1988;19:604-7. 23. Mahoney FI, Barthel DW. Functional Evaluation: The Barthel Index. Md State Med J 1965;14:61-5. 24. EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208. 25. Bonsignore M, Barkow K, Jessen F, Heun R. Validity of the five-item WHO Well-Being Index (WHO-5) in an elderly population. Eur Arch Psychiatry Clin Neurosci 2001;251 Suppl 2:II27-31. 26. Kiekens C, Van Rie K, Leys M, Cleemput I, Smet M, Kesteloot K, et al. [Organisation and

Open access
Economic evaluation of resonable nutrition support

References 1. Wang M, Liu Y. Research on the cost control of clinical nutritional therapy and relevant policies. Chin J Med Guide 2007;9:517-20. 2. Lochs II, Pirhanl C, AIlison SP. Evidence supports nutritional support. Clin Nutr 2006;25:177-9. 3. Jie B, Jiang ZM. Impact of parenteral and enteral nutrition support on the outcome of patients with nutrition risk. Chin J Clin Appl, 2009;17:127-8. 4. Dvir D, Cohen J, Singer P. Computerized energy balance and complications in critically ill patients

Open access
Systemic corticosteroids in acute exacerbation of chronic obstructive pulmonary disease

References 1. Leuppi JD, Schuetz P, Bingisser R, Bodmer M, Briel M, Drescher T, et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA 2013;309:2223-31. 2. Abroug F, Ouanes-Besbes L, Fkih-Hassen M, Ouanes I, Ayed S, Dachraoui F, et al. Prednisone in COPD exacerbation requiring ventilatory support: an open-label randomised evaluation. Eur Respir J 2014;43:717-24. 3. Kiser TH, Allen RR, Valuck RJ, Moss M

Open access
“Position Paper” Timely Insulinisation in Type 2 Diabetes Patients

References 1. accesed on 25th June 2012. 2. Handelsman Y, Mechanick JI, Blonde L et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract 17[Suppl 2]: 1-53, 2011. 3. The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative metaanalysis of 102 prospective

Open access
Dr. Google, The Specialist in Diabetes and Metabolic Diseases

://–985828#.U5i6znYdSKH. 4. Aungst T. Apple still leads Android in total number of medical apps. iMedicalApps, 2013. [Online]. 5. Borel B. Health policy brief: mHealth and FDA Regulations. Health Affairs, 2013. [Online]. 6. *** How smartphones are on the verge of taking over the world. New York Daily News, 2013. [Online]. 7. Aitken M

Open access
Clinical significance of airway mucus hypersecretion in chronic obstructive pulmonary disease

References 1. World Health Organization. World Health Statistics 2008 [EB/OL]. Available at: Access on March 23, 2015. 2. Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med 2010; 363: 2233-47. 3. Guo W, Zhang J. Study and clinical treatment of patients with chronic obstructive pulmonary disease of airway mucus hypersecretion. Chin J Pract Intern Med 2007; 27: 1390-4. 4. Sherman CB, Xu X, Speizer FE, Ferris BG Jr, Weiss ST

Open access
New Insight into the Role of Obstructive Sleep Apnea in Cardiometabolic Diseases

patients with type 2 diabetes mellitus: a prospective study on sensitivity of Berlin and STOP-Bang questionnaires. Sleep Med 26: 71-76, 2016. 7. Jonas DE, Amick HR, Feltner C et al. Screening for obstructive sleep apnea in adults: an evidence review for the U.S. Preventive Services Task Force. Evidence synthesis number 146. Rockville (MD): Agency for Healthcare Research and Quality (US). Report No: 14-05216-EF-1, 2017. Accessed on 20 th February 2017 at 8. Rasche K, Keller T, Hader C, Leidag M, Prinz

Open access
Chronic Kidney Disease-Mineral Bone Disorder in Diabetes Mellitus Patients

References Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 298(17): 2038-2047, 2007. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462.293 adults in Taiwan. Lancet 371(9631): 2173-2182, 2008. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296

Open access
Impact of Metabolic Status on the Course of Atrial Fibrillation

. Cardiovasc Diagn Ther 5(5): 364-373, 2015. 11. Al-Goblan AS, Al-Alfi MA, Khan MZ. Mechanism linking diabetes mellitus and obesity. Diabetes Metab Syndr Obes 7: 587-591, 2014. 12. Koivumaa-Honkanen H, Honkanen R, Viinamäki H, Heikkilä K, Kaprio J, Koskenvuo M. Self-reported Life Satisfaction and 20-Year Mortality in Healthy Finnish Adults. Am J Epidemiol 152(10): 983-991, 2000. 13. Watanabe H, Tanabe N, Watanabe T et al. Metabolic Syndrome and Risk of Development of Atrial Fibrillation: The Niigata Preventive Medicine Study

Open access